1. Home
  2. SLGN vs CRSP Comparison

SLGN vs CRSP Comparison

Compare SLGN & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silgan Holdings Inc.

SLGN

Silgan Holdings Inc.

N/A

Current Price

$42.39

Market Cap

5.0B

Sector

Industrials

ML Signal

N/A

CRSP

CRISPR Therapeutics AG

N/A

Current Price

$59.50

Market Cap

5.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLGN
CRSP
Founded
1987
2013
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.0B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
SLGN
CRSP
Price
$42.39
$59.50
Analyst Decision
Strong Buy
Buy
Analyst Count
9
17
Target Price
$52.78
$70.29
AVG Volume (30 Days)
1.4M
1.5M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
2.02%
N/A
EPS Growth
4.65
N/A
EPS
1.31
N/A
Revenue
$4,489,927,000.00
$289,590,000.00
Revenue This Year
$4.99
$807.72
Revenue Next Year
$2.20
$172.52
P/E Ratio
$31.39
N/A
Revenue Growth
0.92
9169.85
52 Week Low
$35.68
$44.12
52 Week High
$49.41
$78.48

Technical Indicators

Market Signals
Indicator
SLGN
CRSP
Relative Strength Index (RSI) 48.22 67.33
Support Level $41.98 $50.17
Resistance Level $43.74 $60.10
Average True Range (ATR) 1.01 2.32
MACD -0.00 0.91
Stochastic Oscillator 69.89 78.95

Price Performance

Historical Comparison
SLGN
CRSP

About SLGN Silgan Holdings Inc.

Silgan Holdings Inc is a manufacturer of sustainable rigid packaging solutions for the world's essential consumer goods products. Its products include: dispensing and specialty closures for fragrance and beauty, food, beverage, personal and health care, home care and lawn and garden products; steel and aluminum containers for pet and human food and general line products; and custom designed plastic containers for pet and human food, consumer health and pharmaceutical, personal care, home care, lawn and garden and automotive products.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: